Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,313 | 453 | 99.5% |
| Education | $30.86 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,130 | 20 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $865.41 | 66 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $798.12 | 85 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $601.55 | 27 | $0 (2024) |
| Lilly USA, LLC | $560.41 | 47 | $0 (2024) |
| PFIZER INC. | $502.70 | 70 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $393.91 | 46 | $0 (2019) |
| Allergan, Inc. | $208.09 | 15 | $0 (2020) |
| GlaxoSmithKline, LLC. | $192.59 | 17 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $181.32 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $207.41 | 2 | AstraZeneca Pharmaceuticals LP ($115.98) |
| 2021 | $490.32 | 5 | Amgen Inc. ($354.06) |
| 2020 | $177.22 | 4 | Amgen Inc. ($118.89) |
| 2019 | $1,777 | 114 | Janssen Pharmaceuticals, Inc ($303.07) |
| 2018 | $1,683 | 154 | Boehringer Ingelheim Pharmaceuticals, Inc. ($270.91) |
| 2017 | $2,009 | 179 | Boehringer Ingelheim Pharmaceuticals, Inc. ($318.98) |
All Payment Transactions
458 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $115.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $91.43 | General |
| Category: Obesity | ||||||
| 12/22/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: VACCINES | ||||||
| 10/20/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $106.64 | General |
| Category: Neuroscience | ||||||
| 09/09/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.42 | General |
| Category: Cardiology | ||||||
| 08/05/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 07/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/17/2020 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Stents | ||||||
| 03/10/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Respiratory and Allergy | ||||||
| 03/04/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $118.89 | General |
| Category: Cardiology | ||||||
| 11/08/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Central Nervous System | ||||||
| 10/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $1.52 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Diabetes | ||||||
| 10/15/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Neuroscience | ||||||
| 10/10/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Central Nervous System | ||||||
| 09/26/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Diabetes | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Neuroscience | ||||||
| 09/19/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $124.49 | General |
| Category: Central Nervous System | ||||||
| 09/17/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: UROLOGY | ||||||
| 09/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 502 | 842 | $736,759 | $80,335 |
| 2022 | 8 | 423 | 702 | $599,228 | $64,430 |
| 2021 | 6 | 319 | 528 | $330,435 | $41,833 |
| 2020 | 10 | 924 | 1,464 | $502,239 | $134,301 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 43 | 150 | $230,100 | $24,225 | 10.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 129 | 260 | $186,680 | $22,756 | 12.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 139 | 142 | $104,654 | $11,926 | 11.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 192 | $96,000 | $11,018 | 11.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 73 | $101,397 | $8,514 | 8.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $11,376 | $1,170 | 10.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $6,552 | $725.88 | 11.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 143 | 332 | $239,115 | $25,921 | 10.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 31 | 95 | $145,945 | $16,014 | 11.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 106 | 107 | $79,099 | $8,389 | 10.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 46 | $64,046 | $6,465 | 10.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 63 | $31,537 | $3,458 | 11.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 35 | 35 | $19,176 | $2,048 | 10.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $13,783 | $1,425 | 10.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $6,526 | $709.15 | 10.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 103 | 270 | $168,279 | $21,434 | 12.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 45 | $54,397 | $6,730 | 12.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 75 | 76 | $50,228 | $6,116 | 12.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 97 | $38,301 | $5,184 | 13.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 27 | 27 | $14,893 | $1,645 | 11.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $4,337 | $723.84 | 16.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 256 | 585 | $155,733 | $47,501 | 30.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 59 | 128 | $134,605 | $22,511 | 16.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 115 | 118 | $58,508 | $18,325 | 31.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 207 | 219 | $60,299 | $18,231 | 30.2% |
About Dr. Edgar Emeric, M.D
Dr. Edgar Emeric, M.D is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619978566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edgar Emeric, M.D has received a total of $6,344 in payments from pharmaceutical and medical device companies, with $207.41 received in 2024. These payments were reported across 458 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,313).
As a Medicare-enrolled provider, Emeric has provided services to 2,168 Medicare beneficiaries, totaling 3,536 services with total Medicare billing of $320,898. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 08/02/2005
- Last Updated 05/29/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619978566
Products in Payments
- Repatha (Biological) $678.85
- XARELTO (Drug) $588.84
- FARXIGA (Drug) $395.11
- JARDIANCE (Drug) $327.73
- TRULICITY (Drug) $312.87
- Prolia (Biological) $290.37
- INVOKANA (Drug) $276.57
- TRADJENTA (Drug) $200.90
- JANUVIA (Drug) $189.36
- AJOVY (Drug) $181.32
- CHANTIX (Drug) $160.87
- Aimovig (Biological) $144.66
- STIOLTO RESPIMAT (Drug) $144.56
- STIOLTO (Drug) $139.64
- SYMBICORT (Drug) $130.99
- EUCRISA (Drug) $122.28
- AIMOVIG (Biological) $115.59
- PNEUMOVAX 23 (Biological) $97.35
- ZEPBOUND (Drug) $91.43
- Trintellix (Drug) $90.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475